These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 24580887)

  • 1. Higher proportion of G2P[4] rotaviruses in vaccinated hospitalized cases compared with unvaccinated hospitalized cases, despite high vaccine effectiveness against heterotypic G2P[4] rotaviruses.
    Matthijnssens J; Zeller M; Heylen E; De Coster S; Vercauteren J; Braeckman T; Van Herck K; Meyer N; Pirçon JY; Soriano-Gabarro M; Azou M; Capiau H; De Koster J; Maernoudt AS; Raes M; Verdonck L; Verghote M; Vergison A; Van Damme P; Van Ranst M;
    Clin Microbiol Infect; 2014 Oct; 20(10):O702-10. PubMed ID: 24580887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of rotavirus genotypes in Korea during 2013: an increase in the G2P[4] genotype after the introduction of rotavirus vaccines.
    Kim JS; Kim HS; Hyun J; Kim HS; Song W; Lee KM; Shin SH
    Vaccine; 2014 Nov; 32(48):6396-402. PubMed ID: 25312273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotavirus strain surveillance for three years following the introduction of rotavirus vaccine into Belém, Brazil.
    Guerra SF; Linhares AC; Mascarenhas JD; Oliveira A; Justino MC; Soares LS; Müller EC; Brasil P; Tuboi S; Ortega-Barria E; Colindres R
    J Med Virol; 2015 Aug; 87(8):1303-10. PubMed ID: 25879653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of the monovalent G1P[8] human rotavirus vaccine against hospitalization for severe G2P[4] rotavirus gastroenteritis in Belém, Brazil.
    Justino MC; Linhares AC; Lanzieri TM; Miranda Y; Mascarenhas JD; Abreu E; Guerra SF; Oliveira AS; da Silva VB; Sanchez N; Meyer N; Shafi F; Ortega-Barria E; Soriano-Gabarró M; Colindres RE
    Pediatr Infect Dis J; 2011 May; 30(5):396-401. PubMed ID: 21150692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Live attenuated human rotavirus vaccine, RIX4414, provides clinical protection in infants against rotavirus strains with and without shared G and P genotypes: integrated analysis of randomized controlled trials.
    De Vos B; Han HH; Bouckenooghe A; Debrus S; Gillard P; Ward R; Cheuvart B
    Pediatr Infect Dis J; 2009 Apr; 28(4):261-6. PubMed ID: 19289978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of rotavirus vaccination on rotavirus genotype distribution and diversity in England, September 2006 to August 2016.
    Hungerford D; Allen DJ; Nawaz S; Collins S; Ladhani S; Vivancos R; Iturriza-Gómara M
    Euro Surveill; 2019 Feb; 24(6):. PubMed ID: 30755297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rotavirus genotype and Vesikari score of outpatients in Japan in the vaccine era.
    Ono M; Tsugawa T; Nakata S; Kondo K; Tatsumi M; Tsutsumi H; Kawasaki Y
    Pediatr Int; 2020 May; 62(5):569-575. PubMed ID: 31957129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rotavirus gastroenteritis in Finnish children in 2006-2008, at the introduction of rotavirus vaccination.
    Räsänen S; Lappalainen S; Halkosalo A; Salminen M; Vesikari T
    Scand J Infect Dis; 2011 Jan; 43(1):58-63. PubMed ID: 20807022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Group a rotavirus and norovirus genotypes circulating in the northeastern Brazil in the post-monovalent vaccination era.
    Sá AC; Gómez MM; Lima IF; Quetz JS; Havt A; Oriá RB; Lima AA; Leite JP
    J Med Virol; 2015 Sep; 87(9):1480-90. PubMed ID: 25982627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rotavirus epidemiology 5-6 years after universal rotavirus vaccination: persistent rotavirus activity in older children and elderly.
    Markkula J; Hemming-Harlo M; Salminen MT; Savolainen-Kopra C; Pirhonen J; Al-Hello H; Vesikari T
    Infect Dis (Lond); 2017 May; 49(5):388-395. PubMed ID: 28067093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing molecular epidemiology of rotavirus infection after introduction of monovalent rotavirus vaccination in Scotland.
    Mukhopadhya I; Murdoch H; Berry S; Hunt A; Iturriza-Gomara M; Smith-Palmer A; Cameron JC; Hold GL
    Vaccine; 2017 Jan; 35(1):156-163. PubMed ID: 27876201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G2P[4] the most prevalent rotavirus genotype in 2007 winter season in an European non-vaccinated population.
    Antunes H; Afonso A; Iturriza M; Martinho I; Ribeiro C; Rocha S; Magalhães C; Carvalho L; Branca F; Gray J
    J Clin Virol; 2009 May; 45(1):76-8. PubMed ID: 19375980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Group A rotavirus genotypes circulating prior to implementation of a National Immunization Program in Estonia.
    Soeorg H; Tamm E; Huik K; Pauskar M; Mägi D; Pruudel K; Vainomäe L; Moosar L; Kirss K; Torm S; Närska M; Pütsepp A; Nurm H; Pruunsild K; Jänes A; Zilmer K; Lutsar I
    Hum Vaccin Immunother; 2012 Apr; 8(4):465-9. PubMed ID: 22370511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rotavirus genotype distribution in Kyrgyzstan and Kazakhstan, 2007-2009.
    Vainio K; Latipov R; Utegenova E; Kasymbekova K; Juraev R; Asilova M; Flem E
    APMIS; 2013 May; 121(5):447-55. PubMed ID: 23078218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of rotavirus vaccination in prevention of hospital admissions for rotavirus gastroenteritis among young children in Belgium: case-control study.
    Braeckman T; Van Herck K; Meyer N; Pirçon JY; Soriano-Gabarró M; Heylen E; Zeller M; Azou M; Capiau H; De Koster J; Maernoudt AS; Raes M; Verdonck L; Verghote M; Vergison A; Matthijnssens J; Van Ranst M; Van Damme P;
    BMJ; 2012 Aug; 345():e4752. PubMed ID: 22875947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G1P[8] species A rotavirus over 27 years--pre- and post-vaccination eras--in Brazil: full genomic constellation analysis and no evidence for selection pressure by Rotarix® vaccine.
    da Silva MFM; Rose TL; Gómez MM; Carvalho-Costa FA; Fialho AM; de Assis RMS; de Andrade JDSR; Volotão EM; Leite JPG
    Infect Genet Evol; 2015 Mar; 30():206-218. PubMed ID: 25562122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human rotavirus strains circulating in Venezuela after vaccine introduction: predominance of G2P[4] and reemergence of G1P[8].
    Vizzi E; Piñeros OA; Oropeza MD; Naranjo L; Suárez JA; Fernández R; Zambrano JL; Celis A; Liprandi F
    Virol J; 2017 Mar; 14(1):58. PubMed ID: 28320411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-vaccine rotavirus genotype distribution in Nairobi County, Kenya.
    Gikonyo JN; Mbatia B; Okanya PW; Obiero GFO; Sang C; Steele D; Nyangao J
    Int J Infect Dis; 2020 Nov; 100():434-440. PubMed ID: 32898668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil.
    Correia JB; Patel MM; Nakagomi O; Montenegro FM; Germano EM; Correia NB; Cuevas LE; Parashar UD; Cunliffe NA; Nakagomi T
    J Infect Dis; 2010 Feb; 201(3):363-9. PubMed ID: 20047501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and genomic characterization of G2P[4] group A rotavirus strains during monovalent vaccine introduction in Brazil.
    Gómez MM; Carvalho-Costa FA; Volotão Ede M; Rose TL; da Silva MF; Fialho AM; Assis RM; de Andrade Jda S; Sá AC; Zeller M; Heylen E; Matthijnssens J; Leite JP
    Infect Genet Evol; 2014 Dec; 28():486-94. PubMed ID: 25239525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.